Grace Halsey

Survey: More than half of Gen Z respondents wish they had taken sun protection more seriously when they were younger. Find out where the information gaps are.

Patients with HFpEF who significantly restrict salt consumption have increased risk for cardiovascular and HF events and HF hospitalization, according to new research.

Clinical research into treatments for NASH is hampered by the need for invasive biopsies but a new blood test using 2 biomarkers could be a game changer, say study authors.

Social determinants of health, including education and income level and race/ethnicity, are drivers of declining cardiometabolic health in the US, says investigator Meghan O'Hearn.

A new study compared the differential effects of agents used to treat hypertension on the risk for dementia in patients with hypertension and mild cognitive impairment.

Americans sitting on the cusp of cardiometabolic disease, ie, with prediabetes, prehypertension, overweight but not obesity, need intervention, now.

Chronic kidney disease is underdiagnosed and undertreated across major Western countries, according to findings of the new CaReMe CKD study.

The cloud-based machine learning algorithm allows the stethoscope to identify and differentiate between innocent and structural murmurs that may signal valve disease.

These 11 studies of cardiovascular and metabolic disease prevention, assessment, and treatment were top trending topics on Patient Care in the first half of 2022.

For patients with chronic sinusitis, disease exacerbations often require use of antibiotics and steroids, in addition to medical office visits, all of which impact quality of life.

US prevalence of optimal cardiometabolic health has declined as poor levels have risen significantly over 2 decades. Investigator Meghan O'Hearn, MS, details the research.

Adding salt regularly to food after cooking/preparation may increase risk of premature death by up to 28% and reduce life expectancy by an average of 2 years.

Results of the prespecified analysis from the REGENERATE trial confirm 2019 data demonstrating statistically significant improvement in fibrosis without worsening NASH.

Called SMART WARS, a new study assessed diagnostic utility of the 2 wearable devices in older adults and considered combined device/clinician interpretation of ECG readings.

Lyme disease is surrounded by its own cloud of misinformation. Here are 9 myths you might hear from patients this summer plus the facts-at-a-glance for backup.

When asthma and COPD patients have a continuous relationship with a single provider, ED visits/hospitalizations go down, survival goes up, finds a new systematic review.

Medicare Advantage plans may cut treatment corners to avoid more costly but more effective and targeted therapy for diabetes patients.

The FDA's move could potentially improve Paxlovid access for patients at high risk for severe COVID-19 who have limited access to health care.

Less than 7% of the US population has "optimal" cardiometabolic health, with declines over 20 years significantly affecting racial/ethnic populations.

Drs Mikhail Kosiborod and Neil Skolnik discuss this unique moment in the history of T2D management that offers treatments to address its broad cardiometabolic impact.

In persons with COPD, seasonal influenza and PPSV23 vaccines, separately or together, reduced the risk for COPD- and pneumonia-related hospitalizations.

Suicidal ideation affects 1 in 15 physicians and job-related stress is often a reason for a suicide among them. A new study set out to find specifics.

Authors of this first study to compare the combinations head-to-head suggest that the glycopyrrolate combination is appropriate for long-term COPD management.

Three-quarters of stroke patients in a Swiss registry had at least 1 undiagnosed risk factor at the time of the event, most commonly hyperlipidemia or hypertension.

US CV health is well below ideal, with 80% of adults scoring as only low or moderate in the first published study using AHA's new Life's Essential 8 algorithm.

Slide Show: The AHA added sleep duration to its Life's Simple 7 cardiovascular health construct and updated sections on diet, lipids, blood glucose and smoking.

If the atogepant label is expanded, the drug will be the only gepant approved for the broad indication of prevention of both episodic and chronic migraine.

The new approval for risankizumab makes it the only interleukin-23 inhibitor for moderately to severely active Crohn disease, according to AbbVie.

Lead author of a study of nearly 200 000 adults with type 2 diabetes that revealed significant clinical inertia in the critical period following initial diagnosis expands on the implications.